TP53 and osteosarcoma: From the patient-derived xenograft, we confirmed KDR expression using IHC analysis and using western blot found that while commonly used TP53 null osteosarcoma SaOS2 cells do not express KDR, our TP53P153Δ osteosarcoma PDX robustly expressed KDR (Figure 7B and C).